Business

OSPREY Analysis Shows Survival Benefit for OncoSil Patients

OSPREY Analysis Shows Survival Benefit for OncoSil Patients

Oncosil Medical LtdDecember 2, 20255

OSPREY Analysis Shows Survival Benefit for OncoSil Patients

About this update from Oncosil Medical Ltd

Oncosil Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Oncosil Medical Ltd

More from Oncosil Medical Ltd

OSL Secures $5.6 million from Major Institutional Investors

September 7, 2026

OncoSil Receives FDA Approval for Distal Cholangiocarcinoma

August 16, 2026

All Oncosil Medical Ltd news →